Global Cardiovascular and Renal Outcomes of Reduced GFR

Thomas B, Matsushita K, Abate KH, Al-Aly Z, Amlov J, Asayama K, Atkins R, Badawi A, Ballew SH, Banerjee A, Barregard L, et al. (2017)
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 28(7): 2167-2179.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Abstract / Bemerkung
The burden of premature death and health loss from ESRD is well described. Less is known regarding the burden of cardiovascular disease attributable to reduced GFR. We estimated the prevalence of reduced GFR categories 3, 4, and 5 (not on RRT) for 188 countries at six time points from 1990 to 2013. Relative risks of cardiovascular outcomes by three categories of reduced GFR were calculated by pooled random effects meta-analysis. Results are presented as deaths for outcomes of cardiovascular disease and ESRD and as disability-adjusted life years for outcomes of cardiovascular disease, GFR categories 3, 4, and 5, and ESRD. In 2013, reduced GFR was associated with 4% of deaths worldwide, or 2.2 million deaths (95% uncertainty interval [95% UI], 2.0 to 2.4 million). More than half of these attributable deaths were cardiovascular deaths (1.2 million; 95% UI, 1.1 to 1.4 million), whereas 0.96 million (95% UI, 0.81 to 1.0 million) were ESRD-related deaths. Compared with metabolic risk factors, reduced GFR ranked below high systolic BP, high body mass index, and high fasting plasma glucose, and similarly with high total cholesterol as a risk factor for disability-adjusted life years in both developed and developing world regions. In conclusion, by 2013, cardiovascular deaths attributed to reduced GFR outnumbered ESRD deaths throughout the world. Studies are needed to evaluate the benefit of early detection of CKD and treatment to decrease these deaths.
Erscheinungsjahr
Zeitschriftentitel
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Band
28
Zeitschriftennummer
7
Seite
2167-2179
ISSN
eISSN
PUB-ID

Zitieren

Thomas B, Matsushita K, Abate KH, et al. Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2017;28(7):2167-2179.
Thomas, B., Matsushita, K., Abate, K. H., Al-Aly, Z., Amlov, J., Asayama, K., Atkins, R., et al. (2017). Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 28(7), 2167-2179. doi:10.1681/ASN.2016050562
Thomas, B., Matsushita, K., Abate, K. H., Al-Aly, Z., Amlov, J., Asayama, K., Atkins, R., Badawi, A., Ballew, S. H., Banerjee, A., et al. (2017). Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 28, 2167-2179.
Thomas, B., et al., 2017. Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 28(7), p 2167-2179.
B. Thomas, et al., “Global Cardiovascular and Renal Outcomes of Reduced GFR”, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 28, 2017, pp. 2167-2179.
Thomas, B., Matsushita, K., Abate, K.H., Al-Aly, Z., Amlov, J., Asayama, K., Atkins, R., Badawi, A., Ballew, S.H., Banerjee, A., Barregard, L., Barrett-Connor, E., Basu, S., Bello, A.K., Bensenor, I., Bergstrom, J., Bikbov, B., Blosser, C., Brenner, H., Carrero, J.-J., Chadban, S., Cirillo, M., Cortinovis, M., Courville, K., Dandona, L., Dandona, R., Estep, K., Fernandes, J., Fischer, F., Fox, C., Gansevoort, R.T., Gona, P.N., Gutierrez, O.M., Hamidi, S., Hanson, S.W., Himmelfarb, J., Jassal, S.K., Jee, S.H., Jha, V., Jimenez-Corona, A., Jonas, J.B., Kengne, A.P., Khader, Y., Khang, Y.-H., Kim, Y.J., Klein, B., Klein, R., Kokubo, Y., Kolte, D., Lee, K., Levey, A.S., Li, Y., Lotufo, P., Abd El Razek, H.M., Mendoza, W., Metoki, H., Mok, Y., Muraki, I., Muntner, P.M., Noda, H., Ohkubo, T., Ortiz, A., Perico, N., Polkinghorne, K., Al-Radaddi, R., Remuzzi, G., Roth, G., Rothenbacher, D., Satoh, M., Saum, K.-U., Sawhney, M., Schoettker, B., Shankar, A., Shlipak, M., Silva, D.A.S., Toyoshima, H., Ukwaja, K., Umesawa, M., Vollset, S.E., Warnock, D.G., Werdecker, A., Yamagishi, K., Yano, Y., Yonemoto, N., Zaki, M.E.S., Naghavi, M., Forouzanfar, M.H., Murray, C.J.L., Coresh, J., Vos, T.: Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 28, 2167-2179 (2017).
Thomas, Bemadette, Matsushita, Kunihiro, Abate, Kalkidan Hassen, Al-Aly, Ziyad, Amlov, Johan, Asayama, Kei, Atkins, Robert, Badawi, Alaa, Ballew, Shoshana H., Banerjee, Amitava, Barregard, Lars, Barrett-Connor, Elizabeth, Basu, Sanjay, Bello, Aminu K., Bensenor, Isabela, Bergstrom, Jaclyn, Bikbov, Boris, Blosser, Christopher, Brenner, Hermann, Carrero, Juan-Jesus, Chadban, Steve, Cirillo, Massimo, Cortinovis, Monica, Courville, Karen, Dandona, Lalit, Dandona, Rakhi, Estep, Kara, Fernandes, Joao, Fischer, Florian, Fox, Caroline, Gansevoort, Ron T., Gona, Philimon N., Gutierrez, Orlando M., Hamidi, Samer, Hanson, Sarah Wulf, Himmelfarb, Jonathan, Jassal, Simerjot K., Jee, Sun Ha, Jha, Vivekanand, Jimenez-Corona, Aida, Jonas, Jost B., Kengne, Andre Pascal, Khader, Yousef, Khang, Young-Ho, Kim, Yun Jin, Klein, Barbara, Klein, Ronald, Kokubo, Yoshihiro, Kolte, Dhaval, Lee, Kristine, Levey, Andrew S., Li, Yongmei, Lotufo, Paulo, Abd El Razek, Hassan Magdy, Mendoza, Walter, Metoki, Hirohito, Mok, Yejin, Muraki, Isao, Muntner, Paul M., Noda, Hiroyuki, Ohkubo, Takayoshi, Ortiz, Alberto, Perico, Norberto, Polkinghorne, Kevan, Al-Radaddi, Rajaa, Remuzzi, Giuseppe, Roth, Gregory, Rothenbacher, Dietrich, Satoh, Michihiro, Saum, Kai-Uwe, Sawhney, Monika, Schoettker, Ben, Shankar, Anoop, Shlipak, Michael, Silva, Diego Augusto Santos, Toyoshima, Hideaki, Ukwaja, Kingsley, Umesawa, Mitsumasa, Vollset, Stein Emil, Warnock, David G., Werdecker, Andrea, Yamagishi, Kazumasa, Yano, Yuichiro, Yonemoto, Naohiro, Zaki, Maysaa El Sayed, Naghavi, Mohsen, Forouzanfar, Mohammad H., Murray, Christopher J. L., Coresh, Josef, and Vos, Theo. “Global Cardiovascular and Renal Outcomes of Reduced GFR”. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 28.7 (2017): 2167-2179.

5 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome.
Miller-Hodges E, Anand A, Shah ASV, Chapman AR, Gallacher P, Lee KK, Farrah T, Halbesma N, Blackmur JP, Newby DE, Mills NL, Dhaun N., Circulation 137(5), 2018
PMID: 28978551
Pterostilbene protects against uraemia serum-induced endothelial cell damage via activation of Keap1/Nrf2/HO-1 signaling.
Chen ZW, Miu HF, Wang HP, Wu ZN, Wang WJ, Ling YJ, Xu XH, Sun HJ, Jiang X., Int Urol Nephrol 50(3), 2018
PMID: 29094331
Roxadustat in the treatment of anaemia in chronic kidney disease.
Del Vecchio L, Locatelli F., Expert Opin Investig Drugs 27(1), 2018
PMID: 29254377
Uric acid in chronic kidney disease: the quest for causality continues.
Zoccali C, Mallamaci F., Nephrol Dial Transplant 33(2), 2018
PMID: 29294051
Chronic kidney disease and coronary artery calcification in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Suh-Chiou C, Moysés RM, Bittencourt MS, Bensenor IM, Lotufo PA., Clin Cardiol 40(12), 2017
PMID: 29243272

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 28408440
PubMed | Europe PMC

Suchen in

Google Scholar